Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
2.080
+0.240 (13.04%)
At close: Nov 21, 2024, 4:00 PM
2.000
-0.080 (-3.84%)
After-hours: Nov 21, 2024, 5:58 PM EST
Quince Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -53.26 | -31.39 | -51.66 | -89.95 | -76.85 | -36.98 | |
| Depreciation & Amortization | 0.47 | 0.32 | 0.2 | 0.34 | 0.33 | 0.19 | |
| Loss (Gain) From Sale of Assets | -0.11 | -0.04 | 0.09 | - | - | - | |
| Asset Writedown & Restructuring Costs | 17.13 | 5.97 | 0.96 | - | - | - | |
| Loss (Gain) From Sale of Investments | -2.49 | -2.02 | -0.11 | 0.88 | 0.64 | -0.81 | |
| Stock-Based Compensation | 4.71 | 5.22 | 16.62 | 29.85 | 14.47 | 2.06 | |
| Other Operating Activities | 5.25 | 1.67 | -0.31 | 0.2 | 0.37 | 0.37 | |
| Change in Accounts Payable | -0.55 | -0.29 | -5.94 | 1.36 | 0.48 | 2.58 | |
| Change in Other Net Operating Assets | -1.58 | 2.27 | -3.89 | -5.62 | 9.75 | -0.68 | |
| Operating Cash Flow | -30.43 | -18.29 | -44.04 | -62.93 | -50.82 | -33.28 | |
| Capital Expenditures | -0.15 | -0.16 | -0.13 | -0.18 | -0.05 | -0.06 | |
| Sale of Property, Plant & Equipment | - | 0.09 | 0.07 | - | - | - | |
| Cash Acquisitions | -2.12 | -2.12 | 10.59 | - | - | - | |
| Investment in Securities | 19.2 | -2.57 | 7.47 | 59.13 | -52.38 | -17.69 | |
| Other Investing Activities | -0.5 | -1 | - | - | - | - | |
| Investing Cash Flow | 16.43 | -5.76 | 18 | 58.95 | -52.43 | -17.75 | |
| Long-Term Debt Repaid | - | -0.01 | -0.05 | - | -0.03 | -0.56 | |
| Net Debt Issued (Repaid) | - | -0.01 | -0.05 | - | -0.03 | -0.56 | |
| Issuance of Common Stock | 0.28 | 0.15 | 0.76 | 6.81 | 118.91 | 77.93 | |
| Other Financing Activities | -5 | - | - | - | - | - | |
| Financing Cash Flow | -4.72 | 0.14 | 0.71 | 6.81 | 118.88 | 77.37 | |
| Foreign Exchange Rate Adjustments | -0.24 | 0.08 | 0.18 | 0.06 | - | - | |
| Net Cash Flow | -18.96 | -23.83 | -25.15 | 2.88 | 15.63 | 26.34 | |
| Free Cash Flow | -30.58 | -18.45 | -44.17 | -63.11 | -50.87 | -33.33 | |
| Free Cash Flow Per Share | -0.72 | -0.50 | -1.32 | -2.12 | -1.74 | -1.75 | |
| Levered Free Cash Flow | -13.08 | -1.94 | -24.18 | -30.54 | -24.54 | -20.18 | |
| Unlevered Free Cash Flow | -13.08 | -1.94 | -24.18 | -30.54 | -24.54 | -20.18 | |
| Change in Net Working Capital | -1.31 | -8.08 | 9.56 | 4.11 | -10.02 | -2.11 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.